{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:13:10Z","timestamp":1740136390315,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10072-022-06388-y","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T09:02:56Z","timestamp":1662973376000},"page":"319-327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aseptic meningitis in Fabry disease due to a novel GLA variant: an expanded phenotype?"],"prefix":"10.1007","volume":"44","author":[{"given":"Paulo Ribeiro","family":"N\u00f3brega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Lucas Ara\u00fajo","family":"Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alliane Milliane","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisson Dantas","family":"de Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice Ara\u00fajo","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah Moreira","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabr\u00edcio Oliveira","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson Rodrigues Brand\u00e3o","family":"de Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Paim-Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Luiz Santos","family":"Pessoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-9243","authenticated-orcid":false,"given":"Pedro","family":"Braga-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Martins Maia","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"issue":"21","key":"6388_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"RO Brady","year":"1967","unstructured":"Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L (1967) Enzymatic defect in Fabry\u2019s disease. Ceramidetrihexosidase deficiency. N Engl J Med 276(21):1163\u20131167. https:\/\/doi.org\/10.1056\/NEJM196705252762101","journal-title":"N Engl J Med"},{"key":"6388_CR2","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1016\/S0021-9258(18)51888-3","volume":"238","author":"CC Sweeley","year":"1963","unstructured":"Sweeley CC, Klionsky B (1963) Fabry\u2019s disease: classification as a sphingolipidosis and partial characterization of a novel glycolipid. J Biol Chem 238:3148\u20133150","journal-title":"J Biol Chem"},{"issue":"1","key":"6388_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s10545-006-0196-0","volume":"29","author":"AC Vedder","year":"2006","unstructured":"Vedder AC, Strijland A, vd Bergh Weerman MA, Florquin S, Aerts JM, Hollak CE (2006) Manifestations of Fabry disease in placental tissue. J Inherit Metab Dis. 29(1):106\u201311. https:\/\/doi.org\/10.1007\/s10545-006-0196-0","journal-title":"J Inherit Metab Dis."},{"issue":"33","key":"6388_CR4","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.2174\/13816128113199990345","volume":"19","author":"S Sestito","year":"2013","unstructured":"Sestito S, Ceravolo F, Concolino D (2013) Anderson-Fabry disease in children. Curr Pharm Des 19(33):6037\u20136045. https:\/\/doi.org\/10.2174\/13816128113199990345","journal-title":"Curr Pharm Des"},{"issue":"3","key":"6388_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281(3):249\u2013254. https:\/\/doi.org\/10.1001\/jama.281.3.249","journal-title":"JAMA"},{"issue":"1","key":"6388_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, Ponzone A, Desnick RJ (2006) High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet 79(1):31\u201340. https:\/\/doi.org\/10.1086\/504601","journal-title":"Am J Hum Genet"},{"issue":"5","key":"6388_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","volume":"2","author":"HY Lin","year":"2009","unstructured":"Lin HY, Chong KW, Hsu JH, Yu HC, Shih CC, Huang CH, Lin SJ, Chen CH, Chiang CC, Ho HJ, Lee PC, Kao CH, Cheng KH, Hsueh C, Niu DM (2009) High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet 2(5):450\u2013456. https:\/\/doi.org\/10.1161\/CIRCGENETICS.109.862920","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"6388_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2119\/molmed.2012.00002","volume":"18","author":"YH Chien","year":"2012","unstructured":"Chien YH, Lee NC, Chiang SC, Desnick RJ, Hwu WL (2012) Fabry disease: incidence of the common later-onset \u03b1-galactosidase A IVS4+919G\u2192A mutation in Taiwanese newborns\u2014superiority of DNA-based to enzyme-based newborn screening for common mutations. Mol Med 18(1):780\u2013784. https:\/\/doi.org\/10.2119\/molmed.2012.00002","journal-title":"Mol Med"},{"issue":"1","key":"6388_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0002-9149(00)01275-3","volume":"87","author":"T Yoshitama","year":"2001","unstructured":"Yoshitama T, Nakao S, Takenaka T, Teraguchi H, Sasaki T, Kodama C, Tanaka A, Kisanuki A, Tei C (2001) Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry\u2019s disease. Am J Cardiol 87(1):71\u201375. https:\/\/doi.org\/10.1016\/s0002-9149(00)01275-3","journal-title":"Am J Cardiol"},{"issue":"2","key":"6388_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","volume":"93","author":"WR Wilcox","year":"2008","unstructured":"Wilcox WR, Oliveira JP, Hopkin RJ, Ortiz A, Banikazemi M, Feldt-Rasmussen U, Sims K, Waldek S, Pastores GM, Lee P, Eng CM, Marodi L, Stanford KE, Breunig F, Wanner C, Warnock DG, Lemay RM, Germain DP, Fabry Registry (2008) Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93(2):112\u201328. https:\/\/doi.org\/10.1016\/j.ymgme.2007.09.013","journal-title":"Mol Genet Metab"},{"issue":"4","key":"6388_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","volume":"123","author":"A Ortiz","year":"2018","unstructured":"Ortiz A, Germain DP, Desnick RJ, Politei J, Mauer M, Burlina A, Eng C, Hopkin RJ, Laney D, Linhart A, Waldek S, Wallace E, Weidemann F, Wilcox WR (2018) Fabry disease revisited: management and treatment recommendations for adult patients. Mol Genet Metab 123(4):416\u2013427. https:\/\/doi.org\/10.1016\/j.ymgme.2018.02.014","journal-title":"Mol Genet Metab"},{"issue":"4","key":"6388_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.acvd.2019.01.002","volume":"112","author":"A Hag\u00e8ge","year":"2019","unstructured":"Hag\u00e8ge A, R\u00e9ant P, Habib G, Damy T, Barone-Rochette G, Soulat G, Donal E, Germain DP (2019) Fabry disease in cardiology practice: literature review and expert point of view. Arch Cardiovasc Dis 112(4):278\u2013287. https:\/\/doi.org\/10.1016\/j.acvd.2019.01.002","journal-title":"Arch Cardiovasc Dis"},{"key":"6388_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-444-62702-5.00017-2","volume":"132","author":"R Schiffmann","year":"2015","unstructured":"Schiffmann R (2015) Fabry disease. Handb Clin Neurol 132:231\u2013248. https:\/\/doi.org\/10.1016\/B978-0-444-62702-5.00017-2","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"6388_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tcm.2017.10.001","volume":"28","author":"TR Hsu","year":"2018","unstructured":"Hsu TR, Niu DM (2018) Fabry disease: review and experience during newborn screening. Trends Cardiovasc Med 28(4):274\u2013281. https:\/\/doi.org\/10.1016\/j.tcm.2017.10.001","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"6388_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.amjms.2020.07.011","volume":"360","author":"M Michaud","year":"2020","unstructured":"Michaud M, Mauhin W, Belmatoug N, Garnotel R, Bedreddine N, Catros F, Ancellin S, Lidove O, Gaches F (2020) When and how to diagnose Fabry disease in clinical pratice. Am J Med Sci 360(6):641\u2013649. https:\/\/doi.org\/10.1016\/j.amjms.2020.07.011","journal-title":"Am J Med Sci"},{"issue":"9","key":"6388_CR16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/jnnp.2006.108464","volume":"78","author":"O Lidove","year":"2007","unstructured":"Lidove O, Chauveheid MP, Benoist L, Alexandra JF, Klein I, Papo T (2007) Chronic meningitis and thalamic involvement in a woman: Fabry disease expanding phenotype. J Neurol Neurosurg Psychiatry 78(9):1007. https:\/\/doi.org\/10.1136\/jnnp.2006.108464","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"6388_CR17","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/j.1742-1241.2009.02115.x","volume":"63","author":"O Lidove","year":"2009","unstructured":"Lidove O, Chauveheid MP, Caillaud C, Froissart R, Benoist L, Alamowitch S, Doan S, Szalat R, Baumann N, Alexandra JF, Lavall\u00e9e P, Klein I, Vuillemet F, Sedel F, Sacr\u00e9 K, Samson Y, Roullet E, Papo T (2009) Aseptic meningitis and ischaemic stroke in Fabry disease. Int J Clin Pract 63(11):1663\u20131667. https:\/\/doi.org\/10.1111\/j.1742-1241.2009.02115.x","journal-title":"Int J Clin Pract"},{"issue":"3","key":"6388_CR18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00415-017-8392-4","volume":"264","author":"M Kraemer","year":"2017","unstructured":"Kraemer M, Karabul N, Berlit P, Rolfs A (2017) Evidence for inflammation in Fabry\u2019s disease? Headache and muscle involvement responding to corticosteroid and methotrexate treatment. J Neurol 264(3):595\u2013596. https:\/\/doi.org\/10.1007\/s00415-017-8392-4","journal-title":"J Neurol"},{"issue":"23","key":"6388_CR19","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.2169\/internalmedicine.54.4719","volume":"54","author":"J Sawada","year":"2015","unstructured":"Sawada J, Katayama T, Kano K, Asanome A, Takahashi K, Saito T, Chinda J, Nakagawa N, Sato N, Kimura T, Yahara O, Momosaki K, Nakamura K, Hasebe N (2015) A sporadic case of Fabry disease involving repeated fever, psychiatric symptoms, headache, and ischemic stroke in an adult Japanese woman. Intern Med 54(23):3069\u20133074. https:\/\/doi.org\/10.2169\/internalmedicine.54.4719","journal-title":"Intern Med"},{"issue":"1","key":"6388_CR20","first-page":"27","volume":"13","author":"D Callegaro","year":"2006","unstructured":"Callegaro D, Kaimen-Maciel DR (2006) Fabry\u2019s disease as a differential diagnosis of MS. Int MS J 13(1):27\u201330","journal-title":"Int MS J"},{"issue":"10","key":"6388_CR21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00415-007-0533-8","volume":"254","author":"W Schreiber","year":"2007","unstructured":"Schreiber W, Udvardi A, Kristoferitsch W (2007) Chronic meningitis and lacunar stroke in Fabry disease. J Neurol 254(10):1447\u20131449. https:\/\/doi.org\/10.1007\/s00415-007-0533-8","journal-title":"J Neurol"},{"issue":"5 Pt 1","key":"6388_CR22","first-page":"596","volume":"158","author":"X Perrot","year":"2002","unstructured":"Perrot X, Nighoghossian N, Derex L, Hermier M, Guffon N, Boulliat J, Trouillas P (2002) Accidents isch\u00e9miques vert\u00e9brobasilaires et m\u00e9ningite aseptique compliquant une maladie de Fabry [Vertebro-basilar ischemic strokes and aseptic meningitis, late complications of Fabry\u2019s disease]. Rev Neurol (Paris) 158(5 Pt 1):596\u20138 (French)","journal-title":"Rev Neurol (Paris)"},{"issue":"4","key":"6388_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/ncn3.168","volume":"3","author":"F Yanagimura","year":"2015","unstructured":"Yanagimura F, Fukushima T, Sakamaki Y, Nakamura G, Maruyama H, Makino K (2015) Fabry disease associated with chronic meningitis and cerebral infarction. Neurol Clin Neurosci 3(4):147\u2013149. https:\/\/doi.org\/10.1111\/ncn3.168","journal-title":"Neurol Clin Neurosci"},{"issue":"8","key":"6388_CR24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1526-4610.1995.hed3508498.x","volume":"35","author":"E Uyama","year":"1995","unstructured":"Uyama E, Ueno N, Uchino M, Narahara T, Owada M, Taketomi T, Ando M (1995) Headache associated with aseptic meningeal reaction as clinical onset of Fabry\u2019s disease. Headache 35(8):498\u2013501. https:\/\/doi.org\/10.1111\/j.1526-4610.1995.hed3508498.x","journal-title":"Headache"},{"issue":"7","key":"6388_CR25","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/jnnp.48.7.714","volume":"48","author":"JJ Dubost","year":"1985","unstructured":"Dubost JJ, Viallard IL, Sauvezie B (1985) Chronic meningitis in Fabry\u2019s disease. J Neurol Neurosurg Psychiatry 48(7):714\u2013715. https:\/\/doi.org\/10.1136\/jnnp.48.7.714","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"6388_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","volume":"30","author":"CM Eng","year":"2007","unstructured":"Eng CM, Fletcher J, Wilcox WR, Waldek S, Scott CR, Sillence DO, Breunig F, Charrow J, Germain DP, Nicholls K, Banikazemi M (2007) Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J Inherit Metab Dis 30(2):184\u2013192. https:\/\/doi.org\/10.1007\/s10545-007-0521-2","journal-title":"J Inherit Metab Dis"},{"issue":"10","key":"6388_CR27","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","volume":"28","author":"A Linhart","year":"2007","unstructured":"Linhart A, Kampmann C, Zamorano JL, Sunder-Plassmann G, Beck M, Mehta A, Elliott PM, European FOS Investigators (2007) Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J 28(10):1228\u201335. https:\/\/doi.org\/10.1093\/eurheartj\/ehm153","journal-title":"Eur Heart J"},{"issue":"10","key":"6388_CR28","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/hmg\/3.10.1795","volume":"3","author":"CM Eng","year":"1994","unstructured":"Eng CM, Niehaus DJ, Enriquez AL, Burgert TS, Ludman MD, Desnick RJ (1994) Fabry disease: twenty-three mutations including sense and antisense CpG alterations and identification of a deletional hot-spot in the alpha-galactosidase A gene. Hum Mol Genet 3(10):1795\u20131799. https:\/\/doi.org\/10.1093\/hmg\/3.10.1795","journal-title":"Hum Mol Genet"},{"issue":"2","key":"6388_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","volume":"47","author":"T DeGraba","year":"2000","unstructured":"DeGraba T, Azhar S, Dignat-George F, Brown E, Bouti\u00e8re B, Altarescu G, McCarron R, Schiffmann R (2000) Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol 47(2):229\u201333","journal-title":"Ann Neurol"},{"issue":"2","key":"6388_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.bbadis.2011.11.001","volume":"1822","author":"GB Biancini","year":"2012","unstructured":"Biancini GB, Vanzin CS, Rodrigues DB, Deon M, Ribas GS, Barschak AG, Manfredini V, Netto CBO, Jardim LB, Giugliani R, Vargas CR (2012) Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy. Biochim Biophys Acta (BBA) - Mol Basis Dis 1822(2):226\u2013232. https:\/\/doi.org\/10.1016\/j.bbadis.2011.11.001","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"12","key":"6388_CR31","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1212\/01.WNL.0000166000.24321.4F","volume":"64","author":"G Altarescu","year":"2005","unstructured":"Altarescu G, Moore DF, Schiffmann R (2005) Effect of genetic modifiers on cerebral lesions in Fabry disease. Neurology 64(12):2148\u20132150. https:\/\/doi.org\/10.1212\/01.WNL.0000166000.24321.4F","journal-title":"Neurology"},{"issue":"1","key":"6388_CR32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1590\/s0066-782x2008000100009","volume":"90","author":"AC Zago","year":"2008","unstructured":"Zago AC, Simon DI, Wang Y, Sakuma M, Chen Z, Croce K, Ustinov V, Shi C, Martinez Filho EE (2008) The importance of the interaction between leukocyte integrin Mac-1 and platelet glycoprotein Ib-a for leukocyte recruitment by platelets and for the inflammatory response to vascular injury. Arq Bras Cardiol. 90(1):54\u201363. https:\/\/doi.org\/10.1590\/s0066-782x2008000100009 (English, Portuguese)","journal-title":"Arq Bras Cardiol."},{"issue":"4","key":"6388_CR33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/archneur.1971.00490040077009","volume":"25","author":"HO Lou","year":"1971","unstructured":"Lou HO, Reske-Nielsen E (1971) the central nervous system in Fabry\u2019s disease. A clinical, pathological, and biochemical investigation. Arch Neurol 25(4):351\u20139. https:\/\/doi.org\/10.1001\/archneur.1971.00490040077009","journal-title":"Arch Neurol"},{"issue":"1","key":"6388_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ymgme.2013.02.003","volume":"109","author":"PN De Francesco","year":"2013","unstructured":"De Francesco PN, Mucci JM, Ceci R, Fossati CA, Rozenfeld PA (2013) Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide. Mol Genet Metab 109(1):93\u201399. https:\/\/doi.org\/10.1016\/j.ymgme.2013.02.003","journal-title":"Mol Genet Metab"},{"issue":"8","key":"6388_CR35","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1084\/jem.188.8.1529","volume":"188","author":"FM Spada","year":"1998","unstructured":"Spada FM, Koezuka Y, Porcelli SA (1998) CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 188(8):1529\u20131534. https:\/\/doi.org\/10.1084\/jem.188.8.1529","journal-title":"J Exp Med"},{"issue":"1","key":"6388_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ymgme.2012.02.014","volume":"106","author":"MF Macedo","year":"2012","unstructured":"Macedo MF, Quinta R, Pereira CS, Sa Miranda MC (2012) Enzyme replacement therapy partially prevents invariant natural killer T cell deficiency in the Fabry disease mouse model. Mol Genet Metab 106(1):83\u201391. https:\/\/doi.org\/10.1016\/j.ymgme.2012.02.014","journal-title":"Mol Genet Metab"},{"issue":"12","key":"6388_CR37","doi-asserted-by":"publisher","first-page":"e28648","DOI":"10.1371\/journal.pone.0028648","volume":"6","author":"V O\u2019Reilly","year":"2011","unstructured":"O\u2019Reilly V, Zeng SG, Bricard G, Atzberger A, Hogan AE, Jackson J, Feighery C, Porcelli SA, Doherty DG (2011) Distinct and overlapping effector functions of expanded human CD4+, CD8\u03b1+ and CD4-CD8\u03b1- invariant natural killer T cells. PLoS One 6(12):e28648. https:\/\/doi.org\/10.1371\/journal.pone.0028648","journal-title":"PLoS One"},{"issue":"4","key":"6388_CR38","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/01.asn.0000121781.89599.16","volume":"15","author":"HJ Anders","year":"2004","unstructured":"Anders HJ, Banas B, Schl\u00f6ndorff D (2004) Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 15(4):854\u2013867. https:\/\/doi.org\/10.1097\/01.asn.0000121781.89599.16","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"6388_CR39","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1681\/ASN.2007040395","volume":"19","author":"MC Banas","year":"2008","unstructured":"Banas MC, Banas B, Hudkins KL, Wietecha TA, Iyoda M, Bock E, Hauser P, Pippin JW, Shankland SJ, Smith KD, Stoelcker B, Liu G, Gr\u00f6ne HJ, Kr\u00e4mer BK, Alpers CE (2008) TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 19(4):704\u201313. https:\/\/doi.org\/10.1681\/ASN.2007040395","journal-title":"J Am Soc Nephrol"},{"key":"6388_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/TCRM.S11987","volume":"7","author":"M Alfadhel","year":"2011","unstructured":"Alfadhel M, Sirrs S (2011) Enzyme replacement therapy for Fabry disease: some answers but more questions. Ther Clin Risk Manag 7:69\u201382. https:\/\/doi.org\/10.2147\/TCRM.S11987","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"6388_CR41","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/archopht.1978.03910050421003","volume":"96","author":"NA Sher","year":"1978","unstructured":"Sher NA, Reiff W, Letson RD, Desnick RJ (1978) Central retinal artery occlusion complicating Fabry\u2019s disease. Arch Ophthalmol 96(5):815\u2013817. https:\/\/doi.org\/10.1001\/archopht.1978.03910050421003","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"6388_CR42","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/aos.12588","volume":"93","author":"HC Fledelius","year":"2015","unstructured":"Fledelius HC, Sandfeld L, Rasmussen \u00c5K, Madsen CV, Feldt-Rasmussen U (2015) Ophthalmic experience over 10 years in an observational nationwide Danish cohort of Fabry patients with access to enzyme replacement. Acta Ophthalmol 93(3):258\u2013264. https:\/\/doi.org\/10.1111\/aos.12588","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"6388_CR43","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1755-3768.1994.tb07193.x","volume":"72","author":"MV Andersen","year":"1994","unstructured":"Andersen MV, Dahl H, Fledelius H, Nielsen NV (1994) Central retinal artery occlusion in a patient with Fabry\u2019s disease documented by scanning laser ophthalmoscopy. Acta Ophthalmol (Copenh) 72(5):635\u2013638. https:\/\/doi.org\/10.1111\/j.1755-3768.1994.tb07193.x","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"24","key":"6388_CR44","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa1803396","volume":"380","author":"MR Wilson","year":"2019","unstructured":"Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J, Federman S, Stryke D, Briggs B, Langelier C, Berger A, Douglas V, Josephson SA, Chow FC, Fulton BD, DeRisi JL, Gelfand JM, Naccache SN, Bender J, Dien Bard J, Murkey J, Carlson M, Vespa PM, Vijayan T, Allyn PR, Campeau S, Humphries RM, Klausner JD, Ganzon CD, Memar F, Ocampo NA, Zimmermann LL, Cohen SH, Polage CR, DeBiasi RL, Haller B, Dallas R, Maron G, Hayden R, Messacar K, Dominguez SR, Miller S, Chiu CY (2019) Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med 380(24):2327\u20132340. https:\/\/doi.org\/10.1056\/NEJMoa1803396","journal-title":"N Engl J Med"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06388-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06388-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06388-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:00:38Z","timestamp":1672981238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06388-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["6388"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06388-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2022,9,12]]},"assertion":[{"value":"30 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research has been approved by the local ethics committee under the number 2.118.556.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The patient has signed an informed consent form for publication of her clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}